MiLOC Group Ltd
The group will be principally engaged in (i) the research and development of TCM specifically for pandemic diseases; (ii) the sale and distribution of TCM; and (iii) the development and operation of a network of high quality modern TCM clinics and hospitals in China, Hong Kong and Macau.
| Symbol | Ccy Code | Bid | Ask | Share Price (Mid) | Previous Close | Volume | Last Traded |
|---|---|---|---|---|---|---|---|
| ML.P | GBX | 10 | 30 | 20 | 20 | 1430 | 01.08.18 |
MiFID II compliant pre- and post-trade transaction data is available here. The data is delayed by at least 15 minutes and will be refreshed every 15 minutes. Publication of trades in equity securities that are large in scale compared to normal market size and illiquid non-equity securities may be delayed if the trade is eligible for deferred publication in accordance with the trading rules of Aquis Stock Exchange and MiFIR. Further details as to when the publication of a trade may be deferred are set out in the trading rules which are available here.
Address
Business Address
MiLOC Group Ltd, 8/F, Sino Cheer Plaza, 23 Jordan Road, Kowloon, Hong Kong, China, People's Republic of.
Email: info@miloc.com
Phone: +852 2110 4221
Registered Address
Windward 1, Regatta Office Park, Grand Cayman, PO BOX 897GT, Cayman Islands.
Contacts
Corporate Adviser
Peterhouse Capital Ltd, 3rd Floor, 80 Cheapside, London, United Kingdom.
Email: info@pcorpfin.com
Phone: +44 (0)20 7469 0930
Registrar
Computershare Investor Services plc (London), 2nd Floor Vintners Place, 68 Upper Thames Street, London, London, EC4V 3BJ, England.
Phone: 0870 703 6025
Research
There is no research available.